tetraspanin CD9 mediates lateral association of MHC class II molecules on the dendritic cell surface

We have found that MHC class II (MHC II) molecules exhibit a distinctive organization on the dendritic cell (DC) plasma membrane. Both in DC lysates and on the surface of living cells, I-A and I-E molecules engaged in lateral interactions not observed on other antigen-presenting cells such as B blas...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 104; no. 1; pp. 234 - 239
Main Authors Unternaehrer, Julia J, Chow, Amy, Pypaert, Marc, Inaba, Kayo, Mellman, Ira
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 02.01.2007
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We have found that MHC class II (MHC II) molecules exhibit a distinctive organization on the dendritic cell (DC) plasma membrane. Both in DC lysates and on the surface of living cells, I-A and I-E molecules engaged in lateral interactions not observed on other antigen-presenting cells such as B blasts. Because DCs and B blasts express MHC II at comparable surface densities, the interaction was not due to simple mass action. Instead, it reflected the selective expression of the tetraspanin CD9 at the DC surface. I-A and I-E molecules coprecipitated with each other and with CD9. The association of heterologous MHC II molecules was abrogated in DCs from CD9⁻/⁻ mice. Conversely, expression of exogenous CD9 in B cells induced MHC II interactions. CD9 is thus necessary for the association of heterologous MHC II, a specialization that would facilitate the formation of MHC II multimers expected to enhance T cell receptor stimulation by DCs.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Communicated by Mark M. Davis, Stanford University School of Medicine, Stanford, CA, November 1, 2006
Present address: Division of Hematology/Oncology, Children's Hospital, Boston, MA 02115.
Author contributions: J.J.U., K.I., and I.M. designed research; J.J.U. and M.P. performed research; J.J.U. and A.C. contributed new reagents/analytic tools; J.J.U., M.P., K.I., and I.M. analyzed data; and J.J.U. and I.M. wrote the paper.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0609665104